Discover how BNDX, a USD-hedged European bond ETF, offers a 3.06% yield amid diverging monetary policies and economic trends ...

Analysts have been eager to weigh in on the Real Estate sector with new ratings on Broadstone Net Lease (BNL – Research Report), Brixmor ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price ...

In a report released today, Tal Liani from Bank of America Securities maintained a Buy rating on Fortinet (FTNT – Research Report). The ...

Nutanix (NTNX) closed the most recent trading day at $70.85, moving -1.03% from the previous trading session. This move lagged the S&P 500's daily gain of 0.36%. On the other hand, the Dow registered ...

BST, a tech-focused fund with high dividend yield, faces performance challenges but offers potential for growth and income ...

(RTTNews) - BioXcel Therapeutics, Inc. (BTAI), Thursday announced a reverse stock split of 1-for-16 to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq ...

BTIG analysts stood firm on their positive stance towards GeneDx (NASDAQ:WGS), reiterating a Buy rating and a $95.00 price target for the company's stock. With analyst targets ranging from $70 to $118 ...

Autolus Therapeutics' obe-cel, branded Aucatzyl, is the first CAR-T therapy approved without a REMS, highlighting its safety and unique mechanism.

Gentex (NASDAQ:GNTX – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at B. Riley in a ...

Investors are assessing China's instant retaliation to Trump's additional tariffs, amid worries about the risk of a trade war ...